Read news items items specific to Ponce Therapeutics or about other Rapha Capital-related entities. Also see scientific articles detailing the rapid advances in the important science of anti-aging
ControlRad, Inc. ControlRad Announces First Clinical Use of ControlRad Trace Radiation Reduction Technology Niagara Falls Memorial Medical Center First to Integrate Newly Cleared ControlRad Trace into Fluoroscopically Guided Procedures, Improving…
Asclepix Therapeutics, Inc. AsclepiX Therapeutics Selected to Present at Ophthalmology Innovation Summit (OIS) at the American Society for Retinal Surgeons (ASRS) Annual Conference To Provide Update on AXT107 Duration of…
Bellicum Pharmaceuticals, Inc. Bellicum Pharmaceuticals Announces Rivo-cel™ Achieves Primary Endpoint in Pediatric Registrational Trial Primary endpoint of event free survival (EFS) rate at 180 days of 90.9 percent reported for…
Marker Therapeutics, Inc. Marker Therapeutics to Report Updated Results from Phase 1/2 Trial with MultiTAA Therapy in Patients with Pancreatic Adenocarcinoma Data selected for oral presentation during a plenary session…
Control Rad™ ControlRad™ Announces FDA Clearance and Launch of the Only Radiation Reduction Technology that Integrates into Mobile C-arms May 22, 2019
Poseida Therapeutics Poseida Therapeutics Receives US FDA Orphan Drug Designation for P-BCMA-101 for the Treatment of Multiple Myeloma May 13, 2019
